InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Decheng Capital Global Life Sciences Fund IV, L.P.. Officer active across 2 companies, notably CG Oncology, Inc.. Cumulatively, 3 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €7m. Activity tracked since 29 January 2024. The latest transaction was filed on 29 January 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations